rs199935023
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PP5_Very_Strong
The NM_003560.4(PLA2G6):c.991G>T(p.Asp331Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000148 in 1,557,154 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D331N) has been classified as Uncertain significance.
Frequency
Consequence
NM_003560.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PLA2G6 | NM_003560.4 | c.991G>T | p.Asp331Tyr | missense_variant | 7/17 | ENST00000332509.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PLA2G6 | ENST00000332509.8 | c.991G>T | p.Asp331Tyr | missense_variant | 7/17 | 1 | NM_003560.4 | P3 | |
ENST00000624072.1 | n.2702C>A | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes ? AF: 0.0000263 AC: 4AN: 152258Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000486 AC: 8AN: 164594Hom.: 0 AF XY: 0.0000229 AC XY: 2AN XY: 87358
GnomAD4 exome AF: 0.0000135 AC: 19AN: 1404778Hom.: 0 Cov.: 31 AF XY: 0.0000101 AC XY: 7AN XY: 693754
GnomAD4 genome ? AF: 0.0000263 AC: 4AN: 152376Hom.: 0 Cov.: 33 AF XY: 0.0000268 AC XY: 2AN XY: 74512
ClinVar
Submissions by phenotype
Infantile neuroaxonal dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Aug 09, 2022 | This sequence change replaces aspartic acid, which is acidic and polar, with tyrosine, which is neutral and polar, at codon 331 of the PLA2G6 protein (p.Asp331Tyr). This variant is present in population databases (rs199935023, gnomAD 0.08%). This missense change has been observed in individual(s) with Parkinson disease (PMID: 21700586, 22213678, 25660576). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 30371). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PLA2G6 protein function. Experimental studies have shown that this missense change affects PLA2G6 function (PMID: 21700586). For these reasons, this variant has been classified as Pathogenic. - |
Autosomal recessive Parkinson disease 14 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 05, 2011 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 10, 2020 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 21700586, 25660576, 22213678, 29454663, 30302010, 31196701, 30772976, 31496990, 32183746, 30088174, 32961396) - |
PLA2G6-associated neurodegeneration Pathogenic:1
Pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Jan 24, 2023 | The p.Asp331Tyr variant in PLA2G6 has been reported in at least 4 individuals with PLA2G6-associated neurodegeneration (PMID: 29454663, 31196701, 22213678) and has been identified in 0.08% (11/13680) of East Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs199935023). Although this variant has been seen in the general population in a heterozygous state, its frequency is not high enough to rule out a pathogenic role. This variant has also been reported in ClinVar (Variation ID#: 30371) and has been interpreted as pathogenic by GeneDx and OMIM. Of the 4 affected individuals, 1 was a compound heterozygote that carried a reported likely pathogenic variants in trans and 2 of those were homozygotes, which increases the likelihood that the p.Asp331Tyr variant is pathogenic (Variant ID: 279875; PMID: 29454663, 31196701, 22213678). In vitro functional studies provide some evidence that the p.Asp331Tyr variant may slightly impact protein function (PMID: 21700586). However, these types of assays may not accurately represent biological function. Animal models in mice have shown that this variant causes PLA2G6-associated neurodegeneration (PMID: 30088174). Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive PLA2G6-associated neurodegeneration. ACMG/AMP Criteria applied: PM3_strong, PS3 (Richards 2015). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at